Skip to main content

Table 6 Comparison between the studied groups regarding the clinical outcome

From: Stenting deferral in primary percutaneous coronary intervention: exploring benefits and suitable interval in heavy thrombus burden

Clinical outcome Group A (4–16 h deferral) Group B (7 days deferral) Group C (immediate) p value
In-hospital outcome Number = 50 Number = 50 Number = 50
Over-all MACE 9 (18%) 8 (16%) 10 (20%) 0.873
 Death 2 (4%) 1 (2%) 1 (2%) 0.773
 Re-infarction 3 (6%) 3 (6%) 6 (12%) 0.443
 Arrhythmias 5 (10%) 5 (10%) 3 (6%) 0.714
 Cardiac decompensation 1 (2%) 2 (4%) 2 (4%) 0.813
 Stroke or TIA 1 (2%) 1 (2%) 1 (2%) 1.000
 Bleeding 3 (6%) 3 (6%) 2 (4%) 0.876
 CIN 4 (8%) 5 (10%) 4 (8%) 0.919
6-month outcome Number = 48 Number = 49 Number = 49  
Over-all MACE 7 (14.6%) 8 (16.3%) 17 (34.7%) 0.029
 Death 1 (2.1%) 2 (4.1%) 3 (6.1%) 0.605
 Non-fatal MI 3 (6.3%) 4 (8.2%) 5 (10.2%) 0.778
 Arrhythmias 3 (6.3%) 3 (6.1%) 6 (12.2%) 0.453
 Heart failure 4 (8.3%) 2 (4.1%) 7 (14.3%) 0.205
 Non-fatal stroke 1 (2.1%) 1 (2%) 2 (4.1%) 0.779
LVEF at 6 months (%) 55 (50–59) 53 (44–58) 49.5 (40–55) 0.009
Change in LVEF (%) 11 (7–16) 8 (5–15) 5 (1.5–10) 0.001